Evaluation of rubella screening in pregnant women

CMAJ. Canadian Medical Association Journal

Volumn 159, Issue 9, 1998, Pages 1091-1097

  Gyorkos, Theresa W ^a,b,e   Tannenbaum, Terry N ^a,b,c   Abrahamowicz, Michal ^a,b   Delage, Gilles ^d   Carsley, John ^b,c   Marchand, Sylvie ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Gouvernement du Quebec   (Canada)

^d INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RUBELLA VACCINE;

ARTICLE; CANADA; CONGENITAL RUBELLA SYNDROME; FEMALE; HUMAN; NORMAL HUMAN; PREGNANCY; RUBELLA; SCREENING; VACCINATION;

EID: 0031759862     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982;2:781-4.
2. Givens KT, Lee DA, Jones T, Ilstrup DM. Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Ophthalmol 1993;77:358-63.
3. Stamos JK, Rowley AH. Timely diagnosis of congenital infections. Pediatr Clin North Am 1994;41:1017-33.
4. Orenstein WA, Preblud SR, Bart KJ, Hinman AR. Methods of assessing the impact of congenital rubella infection. Rev Infect Dis 1985;7(Suppl 1):S22-8.
5. Hutchinson MK, Sandall SR. Congenital TORCH infections in infants and young children: neurodevelopmental sequelae and implications for intervention. Top Early Child Educ 1995;15:65-82.
6. De Serres G, Déry P, Lebel M, Mills E, St-Onge F, Martineau G, et al. Épidémiologie de la rubéole et du syndrome de rubéole congénitale au Québec de 1965 à 1994 [abstract]. Actes du Colloque québécois en maladies infectieuses; 1995 May 7-9; Rimouski, Que.
7. National Advisory Committee on Immunization. Canadian immunization guide. 4th ed. Ottawa: Health Canada; 1993.
8. Health Canada. Mumps and Rubella Consensus Conference. Can Commun Dis Rep 1994;20(19):165-76.
9. Canadian hospital directory. Vol 40. Ottawa: Canadian Hospital Association; 1992-93.
10. Cochran WG. Sampling techniques. New York: John Wiley & Sons; 1963.
11. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
12. Miller CL, Miller E, Waight PA. Rubella susceptibility and the continuing risk of infection in pregnancy. BMJ 1987;294:1277-8.
13. World Health Organization. Rubella - surveillance to December 1990, United Kingdom. Wkly Epidemiol Rec 1991;30:217-20.
14. Galazka A. Rubella in Europe. Epidemiol Infect 1991;107:43-54.
15. Charbonneau S. Étude sur la réceptivité à la rubéole des parturientes. Cité de la santé de Laval 1991-1992 [internal report]. Montreal: Département de médecine sociale et preventive, Université de Montréal; 1994.
16. American College of Obstetrics and Gynecology. Rubella and pregnancy. Int J Gynecol Obstet 1993;42:60-6.
17. Garcia DG, Ewert DP, Mascola L. A survey of hospital postpartum and postabortion rubella vaccination policies in Los Angeles county, 1992. Infect Control Hosp Epidemiol 1993;14(9):513-6.
18. Lee SH, Ewert DP, Frederick PD, Mascola L. Resurgence of congenital rubella syndrome in the 1990s. Report on missed opportunities and failed prevention policies among women of childbearing age. JAMA 1992;257:2616-20.
19. Robertson SE, Cochi SL, Bunn GA, Morse DL, Preblud SR. Preventing rubella: assessing missed opportunities for immunization. Am J Public Health 1987;77:1347-9.
20. Berkeley MIKB, Moffat MAJ, Russell D. Surveillance of antibody to rubella virus in Grampian: closing the immunity gap. BMJ 1991;303:1174-6.
21. Gershorn AA. Present and future challenges of immunizations on the health of our patients. Pediatr Inject Dis J 1995;14:445-9.